Get the Stockscreener App
1.79
7.51%
0.125
Traws Pharma Inc stock is traded at $1.79, with a volume of 169.47K.
It is up +7.51% in the last 24 hours and up +16.99% over the past month.
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.
See More
Previous Close:
$1.665
Open:
$1.66
24h Volume:
169.47K
Relative Volume:
0.15
Market Cap:
$12.64M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+27.86%
1M Performance:
+16.99%
6M Performance:
-31.15%
1Y Performance:
-79.77%
1-Day Range:
$1.60
$1.83
1-Week Range:
$1.34
$1.83
52-Week Range:
$0.97
$19.44
Traws Pharma Inc Stock (TRAW) Company Profile
Name
Traws Pharma Inc
Sector
Industry
Phone
267-759-3680
Address
12 PENNS TRAIL, NEWTOWN
Compare TRAW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRAW
Traws Pharma Inc
|
1.79 | 11.76M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-22 | Initiated | Ladenburg Thalmann | Buy |
| May-18-21 | Initiated | Guggenheim | Buy |
| Mar-01-18 | Reiterated | H.C. Wainwright | Buy |
| Jan-17-18 | Downgrade | Maxim Group | Buy → Hold |
| Oct-09-17 | Initiated | H.C. Wainwright | Buy |
| Apr-27-17 | Initiated | Laidlaw | Buy |
| Jul-01-15 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-15 | Initiated | H.C. Wainwright | Buy |
View All
Traws Pharma Inc Stock (TRAW) Latest News
Real time alert setup for Traws Pharma Inc. performanceMarket Growth Summary & High Conviction Buy Zone Alerts - Newser
Will Traws Pharma Inc. benefit from macro trendsJuly 2025 Momentum & Community Supported Trade Ideas - Newser
Will earnings trigger a reversal in Traws Pharma Inc.2025 Year in Review & Real-Time Stock Price Movement Reports - Newser
How sentiment analysis helps forecast Traws Pharma Inc.Market Weekly Review & Weekly Top Stock Performers List - Newser
Using Ichimoku Cloud for Traws Pharma Inc. technicalsQuarterly Market Summary & Verified Momentum Watchlists - Newser
Published on: 2025-09-06 20:33:59 - Newser
Will Traws Pharma Inc. benefit from current market trends2025 Market Sentiment & Stock Timing and Entry Methods - خودرو بانک
What machine learning models say about Traws Pharma Inc.Portfolio Value Report & Real-Time Volume Analysis Alerts - Newser
Relative strength of Traws Pharma Inc. in sector analysisNew Guidance & Low Risk Entry Point Tips - Newser
How moving averages guide Traws Pharma Inc. tradingExit Point & Momentum Based Trading Ideas - Newser
Real time scanner hits for Traws Pharma Inc. explained2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - Newser
Using Bollinger Bands to evaluate Traws Pharma Inc.Quarterly Profit Summary & High Conviction Buy Zone Picks - Newser
How to integrate Traws Pharma Inc. into portfolio analysis toolsWeekly Volume Report & Accurate Entry and Exit Point Alerts - Newser
Traws Pharma Earnings Call: Optimism Amid Challenges - MSN
What to expect from Traws Pharma Inc. in the next 30 daysJuly 2025 Closing Moves & Technical Analysis for Trade Confirmation - Newser
How to build a dashboard for Traws Pharma Inc. stockEarnings Risk Summary & Expert Curated Trade Setup Alerts - Newser
Traws Pharma Inc. recovery potential after sell offJuly 2025 Spike Watch & Accurate Buy Signal Alerts - Newser
Comparing Traws Pharma Inc. in custom built stock radarsWeekly Risk Summary & AI Optimized Trading Strategy Guides - Newser
What high frequency data says about Traws Pharma Inc.Stop Loss & Daily Chart Pattern Signal Reports - Newser
Is Traws Pharma Inc. meeting your algorithmic filter criteriaTrade Performance Summary & Verified High Yield Trade Plans - Newser
Is Traws Pharma Inc. stock a value trap2025 Market WrapUp & Accurate Entry/Exit Alerts - خودرو بانک
Can Traws Pharma Inc. sustain its profitabilityJuly 2025 Big Picture & Reliable Trade Execution Plans - خودرو بانک
Traws Pharma (NASDAQ:TRAW) Shares Down 1.4% – Should You Sell? - Defense World
What’s the RSI of Traws Pharma Inc. stockTrend Reversal & Growth Focused Investment Plans - خودرو بانک
Will Traws Pharma Inc. be affected by tariffsJuly 2025 Earnings & Verified Chart Pattern Signals - خودرو بانک
Traws Pharma Inc. Breaks Below Key Support Level getLinesFromResByArray error: size == 0 - 강소기업뉴스
Is Traws Pharma Inc. stock entering bullish territoryTrade Volume Summary & Free Technical Pattern Based Buy Signals - Newser
How to use Fibonacci retracement on Traws Pharma Inc2025 Sector Review & Safe Entry Point Alerts - Newser
Will Traws Pharma Inc. outperform the marketMarket Risk Report & Pattern Based Trade Signal System - Newser
Traws Pharma Inc.’s volatility index tracking explainedLayoff News & Weekly Momentum Stock Picks - Newser
Traws Pharma Inc Stock (TRAW) Financials Data
There is no financial data for Traws Pharma Inc (TRAW). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):